Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.28 USD | +0.85% | -0.05% | -6.15% |
May. 16 | Transcript : Syndax Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM | |
May. 15 | Syndax Pharmaceuticals, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2024 * | 31.52M | Sales 2025 * | 108M | Capitalization | 1.72B |
---|---|---|---|---|---|
Net income 2024 * | -307M | Net income 2025 * | -269M | EV / Sales 2024 * | 53.3 x |
Net cash position 2024 * | 44.29M | Net cash position 2025 * | 203M | EV / Sales 2025 * | 14.1 x |
P/E ratio 2024 * |
-5.69
x | P/E ratio 2025 * |
-6.94
x | Employees | 184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.15% |
Latest transcript on Syndax Pharmaceuticals, Inc.
1 day | +0.85% | ||
1 week | -0.05% | ||
Current month | -4.02% | ||
1 month | -1.41% | ||
3 months | -12.32% | ||
6 months | +30.84% | ||
Current year | -6.15% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Peter Ordentlich
FOU | Founder | 55 | 05-10-10 |
Neil Gallagher
PSD | President | 60 | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 17-03-28 |
Dennis Podlesak
CHM | Chairman | 66 | 08-11-30 |
Pierre Legault
BRD | Director/Board Member | 63 | 17-01-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 20.28 | +0.85% | 821,743 |
24-05-23 | 20.11 | -3.13% | 768,649 |
24-05-22 | 20.76 | +0.48% | 841,771 |
24-05-21 | 20.66 | +2.02% | 992,762 |
24-05-20 | 20.25 | -0.20% | 1,016,662 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.15% | 1.72B | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- SNDX Stock